-
EP2307420
European procedure
Extract from the Register of European Patents
EP About this file: EP2307420
| EP2307420 - NALMEFENE DI-ESTER PRODRUGS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 05.10.2012 Database last updated on 03.05.2025 | Most recent event Tooltip | 09.11.2012 | Lapse of the patent in a contracting state | published on 12.12.2012 [2012/50] | Applicant(s) | For all designated states Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | [2011/47] |
| Former [2011/15] | For all designated states Janssen Pharmaceutica N.V. Turnhoutseweg 30 2340 Beerse / BE | Inventor(s) | 01 /
GUILLAUME, Michel, Joseph, Maurice, André Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 Beerse / BE | 02 /
GAEKENS, Tim Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 Beerse / BE | [2011/48] |
| Former [2011/15] | 01 /
GUILLAUME, Michel, Joseph, Maurice, André Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 Beerse / BE | ||
| 02 /
GAEKENS, Tim Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 Beerse / BE | Representative(s) | Verberckmoes, Filip Gerard Johnson & Johnson Patent Law Department Turnhoutseweg 30 2340 Beerse / BE | [N/P] |
| Former [2011/48] | Verberckmoes, Filip Gerard Janssen Pharmaceutica N.V., J&J Patent Law Department, Turnhoutseweg 30 2340 Beerse / BE | ||
| Former [2011/15] | Verberckmoes, Filip Gerard Janssen Pharmaceutica N.V., J&J Patent Law Department, Turnhoutseweg 30 2340 Beerse / BE | Application number, filing date | 09734161.4 | 23.04.2009 | [2011/15] | WO2009EP54875 | Priority number, date | EP20080155092 | 24.04.2008 Original published format: EP 08155092 | [2011/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009130270 | Date: | 29.10.2009 | Language: | EN | [2009/44] | Type: | A1 Application with search report | No.: | EP2307420 | Date: | 13.04.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.10.2009 takes the place of the publication of the European patent application. | [2011/15] | Type: | B1 Patent specification | No.: | EP2307420 | Date: | 30.11.2011 | Language: | EN | [2011/48] | Search report(s) | International search report - published on: | EP | 29.10.2009 | Classification | IPC: | C07D489/08, A61K31/485, A61P25/32 | [2011/15] | CPC: |
C07D489/08 (EP,US);
A61P25/00 (EP);
A61P25/30 (EP);
A61P25/32 (EP);
A61P43/00 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2011/15] | Extension states | AL | 24.11.2010 | BA | 24.11.2010 | RS | 24.11.2010 | Title | German: | NALMEFENDIESTERPRODRUGS | [2011/15] | English: | NALMEFENE DI-ESTER PRODRUGS | [2011/15] | French: | PROMÉDICAMENTS DIESTERS DE NALMÉFÈNE | [2011/15] | Entry into regional phase | 24.11.2010 | National basic fee paid | 24.11.2010 | Designation fee(s) paid | 24.11.2010 | Examination fee paid | Examination procedure | 24.11.2010 | Examination requested [2011/15] | 01.03.2011 | Amendment by applicant (claims and/or description) | 08.07.2011 | Communication of intention to grant the patent | 14.09.2011 | Fee for grant paid | 14.09.2011 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 08.07.2011 | Opposition(s) | 31.08.2012 | No opposition filed within time limit [2012/45] | Fees paid | Renewal fee | 02.05.2011 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MC | 30.04.2012 | [2012/50] | Cited in | International search | [DA]EP0250796 (DU PONT [US]) [DA] 1-13* claims 1,2; table 1 *; | [A]EP0615756 (NAT SCIENCE COUNCIL [TW]) [A] 1-13 * the whole document * * figures 19,20; table 2 *; | [A]WO2007110636 (RECKITT BENCKISER HEALTHCARE [GB], et al) [A] 1-13 * page 6, lines 25,26; figure 4; examples J,K; claims 1,16,17,21 * |